ShareSoc32 Videos

0

33:04

Forbidden Technologies (FBT) ShareSoc presentation November 2018

Forbidden Technologies (FBT) ShareSoc November presentation By Ian McDonough, CEO & Stephen Streater, Director of R&D Forbidden Technologies plc is a United Kingdom-based company engaged in the development and commercial exploitation of cloud-based video technology. The Company is engaged in developing cloud video platform used for its Forscene professional editing suite, its video social network, […]

23rd November 2018

0

36:16

Ilika (IKA) ShareSoc presentation November 2018

Ilika (IKA) CEO Graeme Purdy and CFO Stephen Boydell give an overview of the company and an update at the ShareSoc Growth Company Seminar on the 14th November 2018. Ilika plc is the holding company. The Company is engaged in the production, design and development of high throughput methods of material synthesis, characterization and screening. […]

16th November 2018

0

41:41

Pelatro (PTRO) ShareSoc presentation November 2018

Pelatro (PTRO) presentation at The ShareSoc Growth Company Seminar 14th November 2018 by Managing Director & Founder Subash Menon and Finance Director Nicholas Hellyer. Pelatro PLC is a United Kingdom-based company that offers precision marketing solutions for telecom industry. The Company’s solutions analyse customer behaviour and customize promotions. Its product enables targeted campaign management. The […]

15th November 2018

0

36:22

Supermarket Income REIT (SUPR) at ShareSoc October 2018

Supermarket Income REIT plc is a United Kingdom-based, closed-ended investment company. The Company intends to carry on business as a real estate investment trust (REIT). The Company’s investment objective is to provide its shareholders with an income together with capital growth by investing in a diversified portfolio of supermarket real estate assets in the United […]

25th October 2018

0

33:33

Bioventix (BVXP) ShareSoc presentation October 2018

Bioventix ShareSoc presentation: October 2018 By Peter Harrison, CEO. Includes full year results year ended 30th June 2018. Bioventix PLC is a United Kingdom-based biotechnology company. The principal activity of the Company is the development and supply of antibodies. The Company specializes in the development of sheep monoclonal antibodies (SMAs) for use in immunodiagnostics focusing […]

15th October 2018

0

36:17

Malvern International (MLVN) ShareSoc presentation September 2018

Malvern International CEO Sam Malafeh and CFO Bharat Guha, present an overview of the group at the ShareSoc Growth company seminar September 2018. Sam Malafeh, CEO Introduction – 00:21 Biographies – 00:43 Group proposition – 04:26 Structure of organisation – 05:46 What Malvern offers – 09:42 Group growth strategy – 10:18 Course delivery model – […]

26th September 2018

0

37:03

Amryt Pharma (AMYT) – Investor presentation at ShareSoc September 2018

Presentation by Amryt Pharma CCO, David Allmond. Amryt Pharma plc is a commercial-stage specialty pharmaceutical company focused on developing and delivering treatments for patients with rare and orphan diseases. The Company is building a diversified portfolio of proprietary drugs to help address some of rare and debilitating illnesses. The team – 00:27 The vision – […]

25th September 2018

0

28:21

International Biotechnology Trust (IBT) presentation at ShareSoc April 2018

IBT presentation at the ShareSoc growth company seminar in April 2018 by Lead Investment Manager Dr Carl Harald Janson. International Biotechnology Trust offers investors access to the fast growing biotechnology sector through an actively managed, diversified fund. Its award winning fund managers at SV Health Investors are scientifically and medically trained with over 60 years […]

17th August 2018

0

28:04

K3 Business Technology (KBT) presentation at ShareSoc July 2018

K3 Business Technology (KBT) presentation at ShareSoc July 2018 By Adalsteinn Valdimarsson, CEO, and Rob Price, CFO. Adalsteinn Valdimarsson, CEO Business overview – 00:34 Product offering – 03:16 Reorganisation/Engagement models – 05:38 Channel partner network – 07:38 H1 results overview – 08:50 Rob Price, CFO H1 financial overview – 10:38 Adalsteinn Valdimarsson, CEO Summary – […]

18th July 2018

0

29:53

MaxCyte (MXCT) presentation at ShareSoc July 2018

Driving the next generation of cell-based medicines By Doug Doerfler – Founder, President & CEO Introduction – 00:23 Background and what MaxCyte does – 02:41 Business model – 04:11 CARMA platform, CAR therapy in oncology – 09:07 Cell therapy programmes – business model – 16:12 Revenue potential across multiple applications – 19:15 Expected news flow […]

16th July 2018